Market Buzz: Theravance Inc. (NASDAQ:THRX), Biogen Idec Inc(NASDAQ:BIIB), Sangamo Biosciences, Inc. (NASDAQ:SGMO)

Lakeway, NY — (US MARKET BUZZ) — 12/19/2014—, an investment community with a special focus on updating investors with recent news on the U.S. stock market about the small and penny stocks, issues news alert on Theravance Inc. (NASDAQ:THRX), Biogen Idec Inc(NASDAQ:BIIB), Sangamo Biosciences, Inc. (NASDAQ:SGMO).

Theravance Inc. (NASDAQ:THRX)’s shares gained 6.32% to $15.23. Shares of Theravance (NASDAQ:THRX) have been given a consensus rating of “Hold” by the eight ratings firms that are currently covering the company, AnalystRatingsNetwork reports on Dec. 6. Two research analysts have rated the stock with a sell recommendation and six have assigned a hold recommendation to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $20.40.

Should Investors Buy THRX After The Recent Development? Find Out Here

Biogen Idec Inc(NASDAQ:BIIB)’s shares gained 6.25% to $353.70. The company on Dec. 3 said it will present data supporting its approved hemophilia therapies at the 56th Annual Meeting of the American Society of Hematology (ASH) taking place in San Francisco, December 6-9. The company will present seven abstracts, including two oral presentations, demonstrating its ongoing commitment to advance innovative science in hematology, with the goal of addressing significant clinical needs and improving patient care.

Is BIIB Going To Rise or Fall After Today’s Price Action? Find Out Here

Sangamo Biosciences, Inc. (NASDAQ:SGMO)’s shares gained 5.43% to $15.72. The company on Dec. 8 announced the presentation of new preclinical data from its proprietary programs for the treatment of lysosomal storage disorders (LSD) and Shire-partnered hemophilia program.  These studies demonstrate the broad applicability of Sangamo’s In Vivo Protein Replacement Platform (IVPRP) for the potentially curative treatment of such diseases, and were presented at the 56th Annual Meeting of the American Society of Hematology (ASH) held in San Francisco from December 5 to 9, 2014.

Can Traders Buy SGMO After The Solid Rally? Get Free Trend Analysis Here

About is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. also provides investors with trend analysis, detailed company profiles, and most importantly a much needed “informational edge” which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at


The assembled information disseminated by is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. does expect that investors will buy and sell securities based on information assembled and presented in PLEASE always do your own due diligence, and consult your financial advisor.

Karen Loftus is a Minnesota native, she grew up in Hastings, Minnesota and graduated from Hastings High School. Her passion for news started at a young age. While in high school, she reported and anchored for the school's Friday news segment. Karen Loftus attended St. Cloud State University, majoring in broadcast journalism and minoring in political science. She joined SCSU's news station, UTVS News, in the beginning of her college career. During the summer of 2011, Karen interned at KSTP-TV in St. Paul where she was able to select and write stories for the Hubbard Broadcasting-owned station's web page and community websites. In her free time, Karen enjoys spending time with family, friends, and her family dog Vinnie. Karen enjoys living in the Midwest because of her love for the changing seasons and for her favorite sport, snowboarding. Karen loves to meet new people and to hear their stories. She is thrilled to be reporting in southern Minnesota and to continue to learn more about her new hometown.